This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Malcolm B. Bowers, Jr, MD

Arch Gen Psychiatry. 1988;45(6):595-596.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The measurement of monoamine metabolites in the plasma of psychiatric patients is now possible thanks to methods that have become available over the past ten years.^1.2 As was true to some degree for investigations in cerebrospinal fluid (CSF), clinical research using these measures in plasma has proceeded without full knowledge of their origin and significance.³ Currently, most investigators believe that both central and peripheral sources contribute to plasma homovanillic acid (HVA) and methoxyhydroxyphenylglycol (MHPG) metabolites of dopamine and norepinephine, respectively. Debrisoquin has been used in some studies in an effort to minimize the peripheral

See also pp 553, 561, and 564.

contribution to plasma monoamine metabolite values.⁴ Diet can be a major contributor to plasma HVA concentrations under certain circumstances,⁵ and diurnal changes have been noted.⁶

Despite incomplete information regarding the processes plasma monoamine metabolites may reflect, a number of interesting clinical findings have already . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.

Footnotes
Accepted for publication Jan 21, 1988.

Reprint requests to Department of Psychiatry, Yale University School of Medicine, Grace Education Building, 25 Park St, New Haven, CT 06519 (Dr Bowers).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?